In a Law360 article, life sciences regulatory & compliance partner Joshua Oyster, counsel Beth Weinman and associate Helen Ryan (all of Washington, D.C.) analyze two draft guidances regarding the U.S. Food and Drug Administration expectations for transitioning medical devices marketed under emergency use authorizations and Covid-19 related enforcement policies to full compliance with FDA regulatory requirements as the Agency looks past the current public health emergency and towards a return to normal operations.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.